Reconsideration of Credé prophylaxis. A study of maternity and neonatal care.
D001431:Bacteriological Techniques; D002690:Chlamydia Infections / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003085:Colic / Q000209:etiology; D003231:Conjunctivitis / Q000139:chemically induced; D003235:Conjunctivitis, Inclusion / Q000453:epidemiology; D004311:Double-Blind Method; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005767:Gastrointestinal Diseases / Q000209:etiology; D006069:Gonorrhea / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008709:Methenamine / Q000009:adverse effects / Q000627:therapeutic use; D009034:Mother-Child Relations; D009878:Ophthalmia Neonatorum / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology; D012835:Silver Nitrate / Q000009:adverse effects / Q000627:therapeutic use*; D014785:Vision, Ocular / Q000187:drug effects
D004338:Drug Combinations; C037124:hexargin; D012835:Silver Nitrate; D008709:Methenamine